Symptoms and Quality of Life in Community Women With Fecal Incontinence

Adil Eddie Bharucha, Alan R. Zinsmeister, G. Richard Locke, Cathy Schleck, Kimberly McKeon, L. Joseph Melton

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Background & Aims: Assessments of symptom severity are necessary to guide therapy in fecal incontinence (FI). However, there is no consensus on how self-reported symptom severity in FI should be measured for this purpose, and the relationship between symptoms of FI and its impact on quality of life (QOL) is not known. Methods: A questionnaire was mailed to an age-stratified random sample of 5300 women identified through the Rochester Epidemiology Project. Symptom severity was assessed by a validated scale (Fecal Incontinence and Constipation Assessment [FICA]), and impact on 15 domains of QOL was evaluated for subjects who had any FI during the past year. The scale incorporated the type, frequency, and amount of FI, as well as the circumstances surrounding FI (ie, urge or passive FI). A QOL-weighted symptom severity score was derived by weighting the responses for these characteristics, in each subject, by the average QOL impact for all subjects who reported that specific symptom characteristic. The relationship between symptom severity and the QOL-weighted symptom severity score was assessed by Spearman rank correlation. Results: Altogether, 2800 of 5300 (53%) women responded to the survey. FI symptoms were mild (45%), moderate (50%), or severe (5%). Among women with FI, the FICA symptom severity scale was strongly correlated (rs = 0.92, P < .0001) with the QOL-weighted symptom severity score. Conclusions: Among unselected women in the community, self-reported symptom severity, rated by the FICA scale, was strongly correlated with the impact of FI on QOL, supporting the use of this scale to assess symptom severity in FI.

Original languageEnglish (US)
Pages (from-to)1004-1009
Number of pages6
JournalClinical Gastroenterology and Hepatology
Volume4
Issue number8
DOIs
StatePublished - Aug 2006

Fingerprint

Fecal Incontinence
Quality of Life
Constipation
Symptom Assessment

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Symptoms and Quality of Life in Community Women With Fecal Incontinence. / Bharucha, Adil Eddie; Zinsmeister, Alan R.; Locke, G. Richard; Schleck, Cathy; McKeon, Kimberly; Melton, L. Joseph.

In: Clinical Gastroenterology and Hepatology, Vol. 4, No. 8, 08.2006, p. 1004-1009.

Research output: Contribution to journalArticle

Bharucha, Adil Eddie ; Zinsmeister, Alan R. ; Locke, G. Richard ; Schleck, Cathy ; McKeon, Kimberly ; Melton, L. Joseph. / Symptoms and Quality of Life in Community Women With Fecal Incontinence. In: Clinical Gastroenterology and Hepatology. 2006 ; Vol. 4, No. 8. pp. 1004-1009.
@article{4625135a3b964ff382454ded595be6e9,
title = "Symptoms and Quality of Life in Community Women With Fecal Incontinence",
abstract = "Background & Aims: Assessments of symptom severity are necessary to guide therapy in fecal incontinence (FI). However, there is no consensus on how self-reported symptom severity in FI should be measured for this purpose, and the relationship between symptoms of FI and its impact on quality of life (QOL) is not known. Methods: A questionnaire was mailed to an age-stratified random sample of 5300 women identified through the Rochester Epidemiology Project. Symptom severity was assessed by a validated scale (Fecal Incontinence and Constipation Assessment [FICA]), and impact on 15 domains of QOL was evaluated for subjects who had any FI during the past year. The scale incorporated the type, frequency, and amount of FI, as well as the circumstances surrounding FI (ie, urge or passive FI). A QOL-weighted symptom severity score was derived by weighting the responses for these characteristics, in each subject, by the average QOL impact for all subjects who reported that specific symptom characteristic. The relationship between symptom severity and the QOL-weighted symptom severity score was assessed by Spearman rank correlation. Results: Altogether, 2800 of 5300 (53{\%}) women responded to the survey. FI symptoms were mild (45{\%}), moderate (50{\%}), or severe (5{\%}). Among women with FI, the FICA symptom severity scale was strongly correlated (rs = 0.92, P < .0001) with the QOL-weighted symptom severity score. Conclusions: Among unselected women in the community, self-reported symptom severity, rated by the FICA scale, was strongly correlated with the impact of FI on QOL, supporting the use of this scale to assess symptom severity in FI.",
author = "Bharucha, {Adil Eddie} and Zinsmeister, {Alan R.} and Locke, {G. Richard} and Cathy Schleck and Kimberly McKeon and Melton, {L. Joseph}",
year = "2006",
month = "8",
doi = "10.1016/j.cgh.2006.01.003",
language = "English (US)",
volume = "4",
pages = "1004--1009",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "8",

}

TY - JOUR

T1 - Symptoms and Quality of Life in Community Women With Fecal Incontinence

AU - Bharucha, Adil Eddie

AU - Zinsmeister, Alan R.

AU - Locke, G. Richard

AU - Schleck, Cathy

AU - McKeon, Kimberly

AU - Melton, L. Joseph

PY - 2006/8

Y1 - 2006/8

N2 - Background & Aims: Assessments of symptom severity are necessary to guide therapy in fecal incontinence (FI). However, there is no consensus on how self-reported symptom severity in FI should be measured for this purpose, and the relationship between symptoms of FI and its impact on quality of life (QOL) is not known. Methods: A questionnaire was mailed to an age-stratified random sample of 5300 women identified through the Rochester Epidemiology Project. Symptom severity was assessed by a validated scale (Fecal Incontinence and Constipation Assessment [FICA]), and impact on 15 domains of QOL was evaluated for subjects who had any FI during the past year. The scale incorporated the type, frequency, and amount of FI, as well as the circumstances surrounding FI (ie, urge or passive FI). A QOL-weighted symptom severity score was derived by weighting the responses for these characteristics, in each subject, by the average QOL impact for all subjects who reported that specific symptom characteristic. The relationship between symptom severity and the QOL-weighted symptom severity score was assessed by Spearman rank correlation. Results: Altogether, 2800 of 5300 (53%) women responded to the survey. FI symptoms were mild (45%), moderate (50%), or severe (5%). Among women with FI, the FICA symptom severity scale was strongly correlated (rs = 0.92, P < .0001) with the QOL-weighted symptom severity score. Conclusions: Among unselected women in the community, self-reported symptom severity, rated by the FICA scale, was strongly correlated with the impact of FI on QOL, supporting the use of this scale to assess symptom severity in FI.

AB - Background & Aims: Assessments of symptom severity are necessary to guide therapy in fecal incontinence (FI). However, there is no consensus on how self-reported symptom severity in FI should be measured for this purpose, and the relationship between symptoms of FI and its impact on quality of life (QOL) is not known. Methods: A questionnaire was mailed to an age-stratified random sample of 5300 women identified through the Rochester Epidemiology Project. Symptom severity was assessed by a validated scale (Fecal Incontinence and Constipation Assessment [FICA]), and impact on 15 domains of QOL was evaluated for subjects who had any FI during the past year. The scale incorporated the type, frequency, and amount of FI, as well as the circumstances surrounding FI (ie, urge or passive FI). A QOL-weighted symptom severity score was derived by weighting the responses for these characteristics, in each subject, by the average QOL impact for all subjects who reported that specific symptom characteristic. The relationship between symptom severity and the QOL-weighted symptom severity score was assessed by Spearman rank correlation. Results: Altogether, 2800 of 5300 (53%) women responded to the survey. FI symptoms were mild (45%), moderate (50%), or severe (5%). Among women with FI, the FICA symptom severity scale was strongly correlated (rs = 0.92, P < .0001) with the QOL-weighted symptom severity score. Conclusions: Among unselected women in the community, self-reported symptom severity, rated by the FICA scale, was strongly correlated with the impact of FI on QOL, supporting the use of this scale to assess symptom severity in FI.

UR - http://www.scopus.com/inward/record.url?scp=33746340886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746340886&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2006.01.003

DO - 10.1016/j.cgh.2006.01.003

M3 - Article

C2 - 16630766

AN - SCOPUS:33746340886

VL - 4

SP - 1004

EP - 1009

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 8

ER -